North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health

Part of paid clinical trials in Newark, New Jersey.

Sponsor
Corey DeStefano
Study ID
NCT07746999
Status
Enrolling By Invitation

Conditions

  • HEPATITIS C (HCV)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

Primary Objective: Assess disparities in liver health outcomes among transgender individuals on GAHT by evaluating liver function markers (transaminases, bilirubin levels, etc), as well as liver elasticity and presence of liver steatosis or Nonalcoholic Fatty Liver Disease (NAFLD) through FibroScan. A total of 60 participants will be recruited throughout the study, with a ratio of 1:1 between transgender participants who have been on GAHT more than 6 months ( = or \> 182 days), and transgender participants who have been on GAHT for less than 6 months ( \< 181 days) at the start of the study. Secondary Objectives: Assess liver health-related risk factors (e.g. obesity, alcohol consumption) in transgender population. Investigate the association between specific hormone regimens and liver function in transgender individuals. Explore potential modifiers of liver health outcomes, such as age, social barriers determinants of health, duration of hormone therapy and adherence to medical guidelines. Change in Quality of Life from baseline to last study visit.

Key Dates

First listed
Aug 5, 2026
Start date
Mar 15, 2025
Status verified
Jul 2026
Primary completion
Mar 15, 2027
Completion
Mar 15, 2027

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: Transgender >6 months on GAHT and Transgender <6 months on GAHT
    A total of 60 participants will be recruited throughout the study, with a ratio of 1:1 between transgender participants who have been on GAHT more than 6 months ( = or \> 182 days), and transgender participants who have been on GAHT for less than 6 months ( \< 181 days) at the start of the study

Primary Outcome Measure

Assess disparities in liver health outcomes among transgender individuals [ Time Frame: Baseline through December 2027 ]

Locations (1)

FacilityCityStateZIPSite coordinators
North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI)NewarkNew Jersey07103-

Find similar trials in Newark, NJ

Related Studies